EMEA-001232-PIP01-11
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0103/2012
|
| PIP number |
EMEA-001232-PIP01-11
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
GlaxoSmithKline Trading Services Limited
United Kingdom
admin@wainwrightassociates.co.uk +44 1628530554 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|